MEDIA, Pa., March 30 /PRNewswire-FirstCall/ -- Synova Healthcare, Inc., a subsidiary of Synova Healthcare Group, Inc. , announced today that Fem-V(TM), a non-invasive test developed to assist women in the diagnosis and appropriate treatment of vaginal infections, will be available at Rite Aid stores at the beginning of May.
For the millions of American women who experience vaginal infections annually, this easy-to-use at-home test will help determine if an over-the- counter treatment may be considered, or if they should seek treatment from a healthcare professional. Unfortunately, there is little awareness among women concerning the appropriate diagnosis of vaginal infections. This can lead to inappropriate and ineffective treatment resulting in serious health risks such as pelvic inflammatory disease. Significant evidence exists demonstrating that women routinely use over-the-counter medications without first identifying the cause of their infection. Bacterial Vaginitis (BV) is the most common cause of vaginal infection. However, commonly used over-the-counter anti-fungal treatments are not effective against BV. The Fem-V(TM) Vaginal Infection Test allows women to determine the likely cause of their symptoms prior to treatment.
“We are very pleased to have Fem-V(TM) available for sale at Rite Aid stores,” stated company President Mr. David Harrison. “Fem-V(TM) represents an important breakthrough in assisting women to determine the most appropriate course of treatment for their vaginal infections. We hope to encourage women who are suffering from the symptoms of vaginal infections to ‘TEST BEFORE YOU TREAT,’ and increase the likelihood of a successful outcome.”
About Synova Healthcare Group, Inc.:
Synova Healthcare Group, Inc. (SNVH) presently operates two wholly owned subsidiaries; Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc. The company distributes rapid, non-invasive medical diagnostics to retail for over-the-counter (OTC) use, and directly to health care providers for point of care (POC) use in the clinical setting. The company’s products are designed to improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “potential” and similar expressions. These statements reflect the Company’s current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Such risk factors are discussed in the Company’s Form SB-2 registration statement (File No. 333-123498), filed with the Securities and Exchange Commission on August 10, 2005, as well as in periodic reports filed with the Commission. There can be no assurance that such factors will not affect the accuracy of such forward-looking statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information set forth in this Press Release including such forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.
Corporate Contact Information: Synova Healthcare Group, Inc. Attn: Mr. Robert Edwards, CFO 1400 N. Providence Road, Ste. 6010 Media, PA 19063 Tel: 610-565-7080 Fax: 610-565-7081 http://www.synovahealthcare.com Inquiries may also be directed to: info@synovahealthcare.com
Synova Healthcare Group, Inc.
CONTACT: Mr. Robert Edwards, CFO, Synova Healthcare Group, Inc.,+1-610-565-7080, Fax: +1-610-565-7081, info@synovahealthcare.com
Web site: http://www.synovahealthcare.com//
